[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0201940D0 - New combination II - Google Patents

New combination II

Info

Publication number
SE0201940D0
SE0201940D0 SE0201940A SE0201940A SE0201940D0 SE 0201940 D0 SE0201940 D0 SE 0201940D0 SE 0201940 A SE0201940 A SE 0201940A SE 0201940 A SE0201940 A SE 0201940A SE 0201940 D0 SE0201940 D0 SE 0201940D0
Authority
SE
Sweden
Prior art keywords
new combination
relates
disease
reflux
thrive
Prior art date
Application number
SE0201940A
Other languages
English (en)
Inventor
Anders Lehmann
Michael Wrangstadh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201940A priority Critical patent/SE0201940D0/sv
Publication of SE0201940D0 publication Critical patent/SE0201940D0/sv
Priority to ARP030102095A priority patent/AR040203A1/es
Priority to PCT/SE2003/001008 priority patent/WO2004000856A1/en
Priority to TW092116257A priority patent/TW200403059A/zh
Priority to AU2003237739A priority patent/AU2003237739A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02Sulfinic acids; Derivatives thereof
    • C07C313/04Sulfinic acids; Esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0201940A 2002-06-20 2002-06-20 New combination II SE0201940D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II
ARP030102095A AR040203A1 (es) 2002-06-20 2003-06-11 Combinacion de un inhibidor del reflujo y una imidazopiridina para el tratamiento de la gerd
PCT/SE2003/001008 WO2004000856A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
TW092116257A TW200403059A (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
AU2003237739A AU2003237739A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II

Publications (1)

Publication Number Publication Date
SE0201940D0 true SE0201940D0 (sv) 2002-06-20

Family

ID=20288298

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II

Country Status (5)

Country Link
AR (1) AR040203A1 (sv)
AU (1) AU2003237739A1 (sv)
SE (1) SE0201940D0 (sv)
TW (1) TW200403059A (sv)
WO (1) WO2004000856A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2006003708A0 (en) 2000-05-26 2006-08-31 Idenix Cayman Ltd Methods and compositions for treating flavivirusesand pestiviruses
RS20050868A (en) * 2003-05-27 2007-08-03 Altana Pharma Ag., Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
BR112014026210A2 (pt) 2012-05-03 2017-06-27 Novartis Ag derivados de sal l-malato de 2,7-diaza-espiro[4.5]dec-7-il e formas cristalinas dos mesmos como agonistas do receptor de grelina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2004000856A1 (en) 2003-12-31
AR040203A1 (es) 2005-03-16
AU2003237739A1 (en) 2004-01-06
TW200403059A (en) 2004-03-01

Similar Documents

Publication Publication Date Title
SE0201940D0 (sv) New combination II
ATE408601T1 (de) Fredericamycin-derivate
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
ATE461217T1 (de) Glp-1-verbindungen
NO20045429L (no) Kombinasjon av organiske forbindelser
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
NO20052591L (no) Pyridopyrolizin og pyridoindolizinderivater
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
EA200500715A1 (ru) Новые лекарственные средства для лечения хронического обструктивного заболевания лёгких
RS52942B (en) TREATMENT OF TYPE 2 DIABETES BY THE COMBINATION OF DPIV IHIBITORS AND METFORMIN OR THIAZOLIDINDION
NO20052512L (no) Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
HRP20050439B1 (en) New use of dextran sulfate
SE0201939D0 (sv) New combination
NO20063790L (no) Substituerte azetidin sammensetninger som cyclooxygenase-1-cyclooxygenase-2-inhibitorer, og deres fremstilling og anvendelse som medikamenter
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität